- Home
- Publications
- Publication Search
- Publication Details
Title
Renin–Angiotensin System Blocking Drugs
Authors
Keywords
-
Journal
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
Volume 19, Issue 1, Pages 14-33
Publisher
SAGE Publications
Online
2013-09-14
DOI
10.1177/1074248413501018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals
- (2016) JOURNAL OF HYPERTENSION
- Association of Angiotensinogen (M235T) Gene Polymorphism with Blood Pressure Lowering Response to Angiotensin Converting Enzyme Inhibitor (Enalapril)
- (2016) Kamna Srivastava et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
- (2013) Daniel Caldeira et al. American Journal of Cardiovascular Drugs
- Angiotensin-converting Enzyme Inhibitors and Outcomes in Heart Failure and Preserved Ejection Fraction
- (2013) Marjan Mujib et al. AMERICAN JOURNAL OF MEDICINE
- Meta-analysis: Effect of Monotherapy and Combination Therapy with Inhibitors of the Renin–Angiotensin System on Proteinuria in Renal Disease
- (2013) Regina Kunz et al. ANNALS OF INTERNAL MEDICINE
- Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II–Receptor Blockers for Ischemic Heart Disease
- (2013) William L. Baker ANNALS OF INTERNAL MEDICINE
- Effect of Telmisartan on Renal Outcomes
- (2013) Johannes F.E. Mann ANNALS OF INTERNAL MEDICINE
- Risk for Incident Atrial Fibrillation in Patients Who Receive Antihypertensive Drugs
- (2013) Beat A. Schaer ANNALS OF INTERNAL MEDICINE
- Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
- (2013) H. Makani et al. BMJ-British Medical Journal
- Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus
- (2012) Michael L. Johnson et al. Alzheimers & Dementia
- Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin–Angiotensin System Inhibitors
- (2012) Harikrishna Makani et al. AMERICAN JOURNAL OF CARDIOLOGY
- Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System
- (2012) Sengwee Toh et al. ARCHIVES OF INTERNAL MEDICINE
- Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis
- (2012) Atle Fretheim et al. BMC Medicine
- Long term use of drugs affecting the renin-angiotensin system and the risk of cancer: a population-based case-control study
- (2012) Jesper Hallas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Blood Pressure in Renal Disease: How to Accomplish the Goal?
- (2012) Nicolás R. Robles et al. Cardiovascular Therapeutics
- Angiotensin-Receptor Blockers and Risk of Alzheimer^|^rsquo;s Disease in Hypertension Population
- (2012) Chien-Yi Hsu et al. CIRCULATION JOURNAL
- Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients
- (2012) L. C. van Vark et al. EUROPEAN HEART JOURNAL
- Pregnancy Outcome Following Exposure to Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Antagonists
- (2012) Marina Bullo et al. HYPERTENSION
- Genomic Association Analysis Identifies Multiple Loci Influencing Antihypertensive Response to an Angiotensin II Receptor Blocker
- (2012) Stephen T. Turner et al. HYPERTENSION
- Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction
- (2012) Lars H. Lund et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Blood Pressure Responses to Hypertension Treatment and Trends in Cognitive Function in Patients With Initially Difficult-to-Treat Hypertension: A Retrospective Subgroup Analysis of the Observational Study on Cognitive Function and SBP Reduction (OSCAR) St
- (2012) Robert J. Petrella et al. Journal of Clinical Hypertension
- Prevention of microalbuminuria in patients with type 2 diabetes and hypertension
- (2012) Jan Menne et al. JOURNAL OF HYPERTENSION
- Dual inhibition of the renin–angiotensin system in high-risk diabetes and risk for stroke and other outcomes
- (2012) Johannes F.E. Mann et al. JOURNAL OF HYPERTENSION
- Aliskiren, the first direct renin inhibitor for treatment of hypertension: The path of its development
- (2012) M Jadhav et al. Journal of Postgraduate Medicine
- A Meta-Analysis Reporting Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Without Heart Failure
- (2012) Gianluigi Savarese et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Angiotensin-Converting Enzyme (ACE) Gene Insertion/Deletion Polymorphism and ACE Inhibitor-Related Cough: A Meta-Analysis
- (2012) Ya-Feng Li et al. PLoS One
- Long-Term Use of Angiotensin Receptor Blockers and the Risk of Cancer
- (2012) Laurent Azoulay et al. PLoS One
- The Role of ARBs Alone or with HCTZ in the Treatment of Hypertension and Prevention of Cardiovascular and Renal Complications
- (2012) Mark K. Greathouse et al. POSTGRADUATE MEDICINE
- Telmisartan on Top of Antihypertensive Treatment Does Not Prevent Progression of Cerebral White Matter Lesions in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) MRI Substudy
- (2012) Ralph Weber et al. STROKE
- Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database
- (2012) K. Bhaskaran et al. BMJ-British Medical Journal
- Meta-Analysis of Randomized Controlled Trials on Effect of Angiotensin-Converting Enzyme Inhibitors on Cancer Risk
- (2011) Ilke Sipahi et al. AMERICAN JOURNAL OF CARDIOLOGY
- Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials
- (2011) G. Tocci et al. AMERICAN JOURNAL OF HYPERTENSION
- Treatment of Hypertension With Renin-Angiotensin System Inhibitors and Renal Dysfunction: A Systematic Review and Meta-Analysis
- (2011) V. Daien et al. AMERICAN JOURNAL OF HYPERTENSION
- Pharmacotherapy of heart failure with normal ejection fraction (HFNEF) - a systematic review
- (2011) Sujit Rajagopalan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies
- (2011) C. Yoon et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- The safety of combining angiotensin-converting-enzyme inhibitors with angiotensin-receptor blockers in elderly patients: a population-based longitudinal analysis
- (2011) F. A. McAlister et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
- (2011) Úna C. Mc Menamin et al. CANCER CAUSES & CONTROL
- Systematic Review and Meta-Analysis: Renin-Angiotensin System Inhibitors in the Prevention of Atrial Fibrillation Recurrences. An Unfulfilled Hope
- (2011) Marcello Disertori et al. CARDIOVASCULAR DRUGS AND THERAPY
- Use of Angiotensin Receptor Blockers and the Risk of Cancer
- (2011) Björn Pasternak et al. CIRCULATION
- Meta-Analysis
- (2011) Ian M. Kronish et al. CIRCULATION
- Cardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk
- (2011) Sheldon W. Tobe et al. CIRCULATION
- Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF) Trial
- (2011) Andreas Goette et al. Circulation-Arrhythmia and Electrophysiology
- Effects of renin–angiotensin system blockades on cardiovascular outcomes in patients with diabetes mellitus: A systematic review and meta-analysis
- (2011) Yoko M. Nakao et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Evidence for a dose effect of renin-angiotensin system inhibition on progression of microalbuminuria in Type 2 diabetes: a meta-analysis
- (2011) C. L. Blacklock et al. DIABETIC MEDICINE
- Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study
- (2011) E. Imai et al. DIABETOLOGIA
- Reno-protective effects of renin–angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis
- (2011) P. Vejakama et al. DIABETOLOGIA
- Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials
- (2011) F. A. McAlister et al. EUROPEAN HEART JOURNAL
- Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis
- (2011) Gang Huang et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex)
- (2011) Toshio Ogihara et al. HYPERTENSION RESEARCH
- Prevention of Recurrent Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers: A Systematic Review and Meta-Analysis of Randomized Trials
- (2011) Rohit Bhuriya et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Safety and Tolerability of the Direct Renin Inhibitor Aliskiren in Combination With Angiotensin Receptor Blockers and Thiazide Diuretics: A Pooled Analysis of Clinical Experience of 12,942 Patients
- (2011) William B. White et al. Journal of Clinical Hypertension
- The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
- (2011) Else Charlotte Sandset et al. LANCET
- Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms
- (2011) YU-JI LEE et al. NEPHROLOGY
- Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials
- (2011) A. Maione et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
- (2011) Hermann Haller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study
- (2011) J. J. Brugts et al. Netherlands Heart Journal
- Compliance, Persistence, Healthcare Resource Use, and Treatment Costs Associated with Aliskiren plus ARB versus ACE Inhibitor plus ARB Combination Therapy
- (2010) Joanne Chang et al. American Journal of Cardiovascular Drugs
- Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis
- (2010) Bret R. Haymore et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Is the Presence of Microalbuminuria a Relevant Marker of Kidney Disease?
- (2010) Richard J. Glassock CURRENT HYPERTENSION REPORTS
- Patients with acute coronary syndromes and elevated levels of natriuretic peptides: the results of the AVANT GARDE-TIMI 43 Trial
- (2010) Benjamin M. Scirica et al. EUROPEAN HEART JOURNAL
- Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease
- (2010) Hiddo J. Lambers Heerspink et al. EUROPEAN HEART JOURNAL
- Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)
- (2010) et al. EUROPEAN HEART JOURNAL
- A Double-Blind, Dose-Response Study of the Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescents with Hypertension
- (2010) Lydie Hazan et al. HYPERTENSION
- Implications of Recently Published Trials of Blood Pressure–Lowering Drugs in Hypertensive or High-Risk Patients
- (2010) Jan A. Staessen et al. HYPERTENSION
- Angiotensin receptor blockers for prevention of new-onset type 2 diabetes: A meta-analysis of 59,862 patients
- (2010) Deng-feng Geng et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Effect of Renin-Angiotensin System Inhibitors on Mortality and Heart Failure Hospitalization in Patients With Heart Failure and Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
- (2010) Ravi V. Shah et al. JOURNAL OF CARDIAC FAILURE
- Meta-Analysis of Renin-Angiotensin-Aldosterone Blockade for Heart Failure in Presence of Preserved Left Ventricular Function
- (2010) Christophe Meune et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Safety and Tolerability of the Direct Renin Inhibitor Aliskiren: A Pooled Analysis of Clinical Experience in More Than 12,000 Patients With Hypertension
- (2010) William B. White et al. Journal of Clinical Hypertension
- Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition
- (2010) Markus P. Schneider et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic variation in the renin—angiotensin system, use of renin—angiotensin system inhibitors and the risk of myocardial infarction
- (2010) Anke-Hilse Maitland-van der Zee et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies
- (2010) Craig Anderson et al. LANCET NEUROLOGY
- Angiotensin-receptor blockade, cancer, and concerns
- (2010) Stevo Julius et al. LANCET ONCOLOGY
- Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials
- (2010) Ilke Sipahi et al. LANCET ONCOLOGY
- Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
- (2010) Sripal Bangalore et al. LANCET ONCOLOGY
- Effect of ACE insertion/deletion and 12 other polymorphisms on clinical outcomes and response to treatment in the life study
- (2010) Børge G. Nordestgaard et al. Pharmacogenetics and Genomics
- Pharmacogenomic testing for angiotensin-converting enzyme inhibitors: getting ready for prime time
- (2010) Simon de Denus PHARMACOGENOMICS
- Meta-Analysis of Combined Therapy with Angiotensin Receptor Antagonists versus ACE Inhibitors Alone in Patients with Heart Failure
- (2010) Andrea Kuenzli et al. PLoS One
- Blood Pressure Variability and Risk of New-Onset Atrial Fibrillation
- (2010) Alastair J.S. Webb et al. STROKE
- Proteinuria as a Surrogate Outcome in CKD: Report of a Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
- (2009) Andrew S. Levey et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
- (2009) Giuseppe Mancia et al. BLOOD PRESSURE
- Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment – a review
- (2009) Peter Bramlage et al. Cardiovascular Diabetology
- Long-Term Antiproteinuric Effect of Dual Renin-Angiotensin System Blockade
- (2009) N.R. Robles et al. Cardiovascular Therapeutics
- Effects of Telmisartan, Ramipril, and Their Combination on Left Ventricular Hypertrophy in Individuals at High Vascular Risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease
- (2009) Paolo Verdecchia et al. CIRCULATION
- Proteinuria, Chronic Kidney Disease, and the Effect of an Angiotensin Receptor Blocker in Addition to an Angiotensin-Converting Enzyme Inhibitor in Patients With Moderate to Severe Heart Failure
- (2009) Inder S. Anand et al. CIRCULATION
- Effect of the Direct Renin Inhibitor Aliskiren, the Angiotensin Receptor Blocker Losartan, or Both on Left Ventricular Mass in Patients With Hypertension and Left Ventricular Hypertrophy
- (2009) Scott D. Solomon et al. CIRCULATION
- Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis
- (2009) P. Verdecchia et al. EUROPEAN HEART JOURNAL
- Angiotensin II receptor blocker-based vs. non-angiotensin II receptor blocker-based therapy in patients with angiographically documented coronary artery disease and hypertension: the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease (HIJ-CREATE)
- (2009) H. Kasanuki et al. EUROPEAN HEART JOURNAL
- Effects of candesartan and amlodipine on cardiovascular events in hypertensive patients with chronic kidney disease: subanalysis of the CASE-J Study
- (2009) Takao Saruta et al. HYPERTENSION RESEARCH
- Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials
- (2009) Craig I Coleman et al. JOURNAL OF HYPERTENSION
- Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study
- (2009) Olivier Hanon et al. JOURNAL OF HYPERTENSION
- Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials
- (2009) Massimo Volpe et al. JOURNAL OF HYPERTENSION
- Antihypertensive effects of double the maximum dose of valsartan in African–American patients with type 2 diabetes mellitus and albuminuria
- (2009) Matthew R Weir et al. JOURNAL OF HYPERTENSION
- Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
- (2009) B. E. de Galan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
- (2009) Marvin A Konstam et al. LANCET
- Renin-Angiotensin-Aldosterone System (RAAS) gene polymorphisms and antihypertensive response to irbesartan in Chinese hypertensives
- (2009) H. Liu et al. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY
- Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design
- (2009) H.-H. Parving et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Valsartan for Prevention of Recurrent Atrial Fibrillation
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes
- (2009) Michael Mauer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Telmisartan on Functional Outcome, Recurrence, and Blood Pressure in Patients With Acute Mild Ischemic Stroke
- (2009) Philip M. W. Bath et al. STROKE
- A Systematic Review of Angiotensin Receptor Blockers in Preventing Stroke
- (2009) Guo-Cai Lu et al. STROKE
- Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: A meta-analysis
- (2008) Saravanan Balamuthusamy et al. AMERICAN HEART JOURNAL
- Effects of Renin-Angiotensin System Blockers on Renal Outcomes and All-cause Mortality in Patients With Diabetic Nephropathy: An Updated Meta-analysis
- (2008) P. A. Sarafidis et al. AMERICAN JOURNAL OF HYPERTENSION
- Antiproteinuric Response to Dual Blockade of the Renin-Angiotensin System in Primary Glomerulonephritis: Meta-analysis and Metaregression
- (2008) Fausta Catapano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Angiotensin II Type 2 Receptor Stimulation
- (2008) Elena Kaschina et al. CIRCULATION
- Effects of the Oral Direct Renin Inhibitor Aliskiren in Patients With Symptomatic Heart Failure
- (2008) John J.V. McMurray et al. Circulation-Heart Failure
- RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection
- (2008) Christian Werner et al. Clinical Research in Cardiology
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡
- (2008) Kenneth Dickstein et al. EUROPEAN JOURNAL OF HEART FAILURE
- Dual renin–angiotensin system blockade: In patients with single functioning kidney and proteinuria
- (2008) N.R. Robles et al. European Journal of Internal Medicine
- The effects of angiotensin-receptor blockers on mortality and morbidity in heart failure: a systematic review
- (2008) M. C. Shibata et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Safety and Tolerability of Angiotensin-Converting Enzyme Inhibitor Versus the Combination of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in Patients With Left Ventricular Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2008) Rachid Lakhdar et al. JOURNAL OF CARDIAC FAILURE
- Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis
- (2008) Gianpaolo Reboldi et al. JOURNAL OF HYPERTENSION
- ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy
- (2008) H.-H. Parving et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
- (2008) Nish Chaturvedi et al. LANCET
- Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
- (2008) Anne Katrin Sjølie et al. LANCET
- Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
- (2008) Johannes FE Mann et al. LANCET
- Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
- (2008) Hans-Henrik Parving et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke
- (2008) Ralph L. Sacco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction between polymorphisms in the renin–angiotensin–system and angiotensin-converting enzyme inhibitor or β-blocker use and the risk of myocardial infarction and stroke
- (2008) H Schelleman et al. PHARMACOGENOMICS JOURNAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started